Results 31 to 40 of about 213,546 (300)

Mesenchymal stem cell-mediated T cell immunosuppression [PDF]

open access: yes, 2017
Besides being a pool forstromal cells and connective tissues, the mesenchymal stem cells (MSCs) as well exert a potent immunosuppression against almost all types of immune cells, particularly T cells.
Al-Graittee, Satar Jabbar Rahi   +2 more
core   +1 more source

FIRST EXPERIENCE OF APPLICATION OF ASSIST CIRCULATION DEVICE USING BIVENTRICULAR TYPE «EXCOR»

open access: yesВестник хирургии имени И.И. Грекова, 2018
The frequency of use of assist blood device as the «bridge» to the heart transplantation increased in last years. An assessment of results of first 7 implantations of assist circulation device using biventricular type «Excor» was made.
M. L. Gordeev   +12 more
doaj   +1 more source

Case Report: A Case Series of Immunobiological Therapy (Anti-TNF-α) for Patients With Erythema Nodosum Leprosum

open access: yesFrontiers in Medicine, 2022
Patients with leprosy may experience a chronic and severe type II leprosy reaction (ENL) erythema nodosum leprosum that may not respond to thalidomide and systemic immunosuppressants or may even cause serious adverse events. We here present four patients
Ana Flávia Moura Mendes   +4 more
doaj   +1 more source

Combinatorial functions of two chimeric antibodies directed to human CD4 and one directed to the a-chain of the human interleukin-2 receptor [PDF]

open access: yes, 1992
The general feasibility of chimerization of monoclonal antibodies (mAbs) has already been shown for a large number of them. In order to evaluate in vitro parameters relevant to immunosuppressive therapy, we have chimerized and synthesized two anti-CD4 ...
Schwirzke, Marina   +10 more
core   +1 more source

Fulminant Myocarditis in Patients With Autoimmune Disease That Requires Extracorporeal Membrane Oxygenation Support [PDF]

open access: yesTexas Heart Institute Journal
Myocarditis is a potentially life-threatening inflammatory disease of the myocardium, often resulting from infectious and immune-mediated responses. Clinical presentation in severe cases often results in a devastating illness requiring extracorporeal ...
Filip Depta, MD, PhD   +5 more
doaj   +1 more source

Immunosuppressive therapy in polymyositis [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 1971
Immunosuppressive drugs were given to seven patients with polymyositis. The in-vitro activity of peripheral blood lymphocytes had previously been studied in five of these patients with findings suggestive of disturbed immunological processes. Some improvement occurred in five cases, but only in two was the improvement marked and sustained.
S, Currie, J N, Walton
openaire   +2 more sources

Cerebral Amyloid Angiopathy- Related Inflammation: A Case Report and Literature Review

open access: yesJournal of the Korean Society of Radiology, 2023
Cerebral amyloid angiopathy-related inflammation (CAA-RI) is an encephalopathy caused by inflammation of β-amyloid peptide deposition in cerebrovascular vessels.
Chanjin Park, Eun Sun Choi, Eunhee Kim
doaj   +1 more source

Cellular Therapies for Immunosuppression [PDF]

open access: yes, 2012
Almost all current therapeutic approaches to inhibit destructive immune responses in autoimmunity are based on antigen non-specific agents, such as cyclosporine A, which systemically suppress the function of virtually all immune effector cells.
Cools, Nathalie   +2 more
openaire   +2 more sources

A Promising New Therapeutic Strategy to Improve Mortality Outcomes in Patients with Moderate to Severe Paraquat Poisoning [PDF]

open access: yesAsia Pacific Journal of Medical Toxicology
Background: Paraquat ingestion is associated with multi-organ failure and high mortality. The lack of management guidelines and an appropriate antidote is concerning.
Bennett Philip   +4 more
doaj   +1 more source

Genetic Therapy Approaches for Ornithine Transcarbamylase Deficiency

open access: yes, 2023
Ornithine transcarbamylase deficiency (OTCD) is the most common urea cycle disorder with high unmet needs, as current dietary and medical treatments may not be sufficient to prevent hyperammonemic episodes, which can cause death or neurological sequelae.
Berna Seker Yilmaz, Paul Gissen
core   +1 more source

Home - About - Disclaimer - Privacy